Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study
Brain and Development · 2026-08 · 48 (4) · 104564
DOI: 10.1016/j.braindev.2026.104564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Development, 2026-08. Verfasst von Elham Rahimian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Haghighat Medical Imaging Research Center, E Janbazan St, PFJW+269, Tehran, Iran. Hauptthemen laut MEDLINE: Canavan Disease, Amidohydrolases. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.
Abstract (Originalsprache)
OBJECTIVE: In this retrospective descriptive study, we aimed to evaluate magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) findings alongside different ASPA gene mutations in patients to enhance understanding of the genetic backgrounds and to explore correlations between MRI findings and genetic mutations. METHODS: Whole exome sequencing (WES) was used for molecular analysis in seven Iranian patients with clinical diagnosis of Canavan disease. MRI and MRS findings were assessed in these patients. Clinical data, biochemical findings, detailed anatomical MRI involvement, and metabolites in MRS were evaluated. The full spectrum of brain abnormalities on conventional MRI and MRS, as well as clinical outcomes were compared with molecular data to provide insights into the neuroimaging and molecular findings in these patients. RESULTS: WES identified pathogenic or likely pathogenic variants in the ASPA gene in the majority of cases. MRI revealed involvement of deep and subcortical white matter, along with the globus pallidus in all cases. Yet, the putamen, caudate, and claustrum were not involved. MRS analysis demonstrated a typical N-acetylaspartate (NAA) peak with increased NAA/Creatine and NAA/Choline ratios. CONCLUSION: Taken together, this study enhances our understanding of the genetic background of Canavan disease among the Iranian population. We propose functional assays or cohort studies for unresolved classifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Haghighat Medical Imaging Research Center, E Janbazan St, PFJW+269, Tehran, Iran.
- Department of Pediatric Neurology, School of Medicine, Mofid Children's Hospital, Tehran, Iran.
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Pediatric Neurology, School of Medicine, Imam Hossein & Mofid Children's Hospitals, Tehran, Iran.
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: s.ghafourifard@sbmu.ac.ir.
Förderung
- Shahid Beheshti University of Medical Sciences
Zitieren
APA
Rahimian, E., Tahsini, M. R., Karimzadeh, P., Khalilian, S., Fathi, M., Miryounesi, M., Farahvash, M. A., Saket, S., & Fard, S. G. (2026). Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study. Brain and Development, 48(4), 104564. https://doi.org/10.1016/j.braindev.2026.104564
Vancouver
Rahimian E, Tahsini MR, Karimzadeh P, Khalilian S, Fathi M, Miryounesi M, et al. Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study. Brain and Development. 2026;48(4):104564. doi:10.1016/j.braindev.2026.104564
BibTeX
@article{Rahimian2026,
author = {Rahimian, Elham and Tahsini, Majid R and Karimzadeh, Parvaneh and Khalilian, Sheyda and Fathi, Mohadeseh and Miryounesi, Mohammad and Farahvash, Mohammad Aidin and Saket, Sasan and Fard, Soudeh Ghafouri},
title = {Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study},
journal = {Brain and Development},
year = {2026},
volume = {48},
number = {4},
pages = {104564},
doi = {10.1016/j.braindev.2026.104564}
}
EUVIMED